Yu Yong 4
4 · GENELUX Corp · Filed May 12, 2026
Research Summary
AI-generated summary of this filing
GENELUX (GNLX) CSO Yu Yong Sells 605 Shares
What Happened
- Yu Yong, Chief Scientific Officer of GENELUX Corp (GNLX), sold 605 shares on 2026-05-11. The reported proceeds were $1,798, based on an average sale price of $2.9726 (range $2.95–$3.02).
- The filing indicates the shares were sold to cover estimated taxes due in connection with the vesting of restricted stock units (RSUs), a common tax-withholding transaction rather than a market-timing trade.
Key Details
- Transaction date: 2026-05-11; Form 4 filed: 2026-05-12 (timely filing).
- Price: weighted average $2.9726; price range $2.95–$3.02.
- Shares sold: 605; proceeds reported: $1,798.
- Shares owned after transaction: Not specified in the information provided in this summary.
- Footnotes: F1 — sale to cover estimated taxes on RSU vesting (tax withholding). F2 — weighted average sale price and price range; detailed per-price quantities available on request.
- Filing timeliness: Timely (filed one day after the transaction), no late-filing flag.
Context
- Sales to cover tax withholding on vested RSUs are routine and do not necessarily indicate the insider’s view on the company’s prospects. For retail investors, outright purchases or large, repeated insider buys tend to carry more informational weight than isolated tax-related sales.
Insider Transaction Report
Form 4
GENELUX CorpGNLX
Yu Yong
Chief Scientific Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-05-11$2.97/sh−605$1,798→ 149,706 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.
- [F2]The weighted average sale price for the transaction reported was $2.9726, and the range of prices were between $2.95 and $3.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Signature
/s/ Thomas Zindrick, J.D., Attorney-in-Fact|2026-05-12